Ultrasound imaging for tissue characterization to assess cardiac re-synchronization therapy in chronic heart failure

用于组织表征的超声成像以评估慢性心力衰竭的心脏再同步治疗

基本信息

  • 批准号:
    18500389
  • 负责人:
  • 金额:
    $ 2.53万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

We obtained ultrasonic radio-frequency (RF) signals in the left ventricular posterior wall, in addition to tissue Doppler strain imaging in patients with chronic heart failure based on DCM. The signals were analyzed to determine correlation dimension (CD) which reflects chaotic behavior of RF signals on the basis of chaos theory. We observed the value of CD in patients with DCM is lower than that of normal subjects. We attempted to explore changes in ultrasonic properties of the myocardium following antihypertensive medication (such as calcium channel blocker or angiotensin receptor blocker) in hypertensive patients. The administration of those drugs caused non-uniform changes in the chaotic nature of the ultrasound signals. Though the mean value of CD did not change, distribution of CD values decreased after medication. In patients with CD of lower 2.8 before medication, there was an increase in CD following administration. This change was associated with an increase in E', an index of LV diastolic filling. Possible reduction of myocardial fibrosis is associated with an increase in the value of CD. We also attempt to estimate the chronic effects of cardiac resynchronization therapy in the future research by using this method as well as tissue Doppler strain imaging in patients with chronic heart failure.
我们获得了超声射频(RF)信号在左心室后壁,除了组织多普勒应变成像的慢性心力衰竭患者的DCM的基础上。根据混沌理论,对信号进行分析,确定反映射频信号混沌行为的关联维数。我们观察到扩张型心肌病患者的CD值低于正常人。我们试图探讨高血压患者服用抗高血压药物(如钙通道阻滞剂或血管紧张素受体阻滞剂)后心肌超声特性的变化。这些药物的施用导致超声信号的混沌性质的不均匀变化。用药后CD均值无变化,但CD值分布降低。在用药前CD低于2.8的患者中,用药后CD增加。这种变化与E '(左室舒张充盈指数)增加有关。心肌纤维化的可能减少与CD值的增加相关。我们也尝试在未来的研究中,通过使用这种方法以及组织多普勒应变成像在慢性心力衰竭患者中估计心脏起搏治疗的慢性效应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of left ventricuiar filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure
急性至慢性舒张性心力衰竭左心室充盈异常的特征及其与血浆脑钠肽水平升高的关系
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakao S;Lee M;et. al.
  • 通讯作者:
    et. al.
Left ventricular geometrical characterization in patients with diastolic heart failure
舒张性心力衰竭患者左心室几何特征
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ezumi A;Lee M;et. al.
  • 通讯作者:
    et. al.
Left ventricular geometrical characterization in patients with diastolic heart failure.
舒张性心力衰竭患者的左心室几何特征。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ezumi A;Nakao S;Goda A;Otsuka M;Matsumoto M;Yoshida C;Eguchi A;Shimoshikiryo M;Naito Y;Lee M;Tsujino T;Masuyama T.
  • 通讯作者:
    Masuyama T.
Loop diuretic precipitated beriberi in a patient after pancreaticoduodenectomy: A case report
  • DOI:
    10.1097/maj.0b013e318068b5d5
  • 发表时间:
    2007-11-01
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Tsujino, Takeshi;Nakao, Shinji;Masuyama, Tohru
  • 通讯作者:
    Masuyama, Tohru
Left ventricular diastolic dysfunction in diabetic patients : pathophysiology and therapeutic implications.
糖尿病患者的左心室舒张功能障碍:病理生理学和治疗意义。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsujino T;Masuyama T;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWABATA Masaaki其他文献

KAWABATA Masaaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure
值得信赖的人工智能,用于慢性心力衰竭的个性化风险评估
  • 批准号:
    10078557
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
    EU-Funded
Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure
光遗传学沉默实现肾去神经支配慢性心力衰竭的抗心律失常作用
  • 批准号:
    10714486
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Inhibitors for Temporal Modulation of T-Lymphocytes during Chronic Heart Failure
慢性心力衰竭期间 T 淋巴细胞时间调节的新型抑制剂
  • 批准号:
    10638340
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
iCardia4HF: A multi-component mHealth app and tailored text-messaging intervention to promote self-care adherence and improve outcomes in patients with chronic heart failure
iCardia4HF:一款多组件移动医疗应用程序和定制短信干预,可促进慢性心力衰竭患者的自我护理依从性并改善预后
  • 批准号:
    10639357
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
Formulation and pharmacokinetics of subcutaneous administration of deferiprone for prevention of chronic heart failure following hemorrhagic myocardial infarction.
皮下注射去铁酮预防出血性心肌梗死后慢性心力衰竭的配方和药代动力学。
  • 批准号:
    10700370
  • 财政年份:
    2023
  • 资助金额:
    $ 2.53万
  • 项目类别:
A clarification of the pathophysiology of sarcopenia with chronic heart failure in the older adults and its treatment strategy
老年人慢性心力衰竭肌肉减少症的病理生理学及治疗策略的阐明
  • 批准号:
    22K11312
  • 财政年份:
    2022
  • 资助金额:
    $ 2.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
I-Corps: Catheter-Based Device to Treat Chronic Heart Failure
I-Corps:治疗慢性心力衰竭的导管装置
  • 批准号:
    2225386
  • 财政年份:
    2022
  • 资助金额:
    $ 2.53万
  • 项目类别:
    Standard Grant
Development of a Novel Chronic Heart Failure Therapy Focusing on Regulation of Hsp90-Client Interaction
开发一种新型慢性心力衰竭疗法,重点关注 Hsp90-客户相互作用的调节
  • 批准号:
    22K15297
  • 财政年份:
    2022
  • 资助金额:
    $ 2.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Relationship between stabilization of autonomic nervous function, change in body composition, and improvement of quality of life in patients with chronic heart failure
慢性心力衰竭患者自主神经功能稳定、身体成分变化与生活质量改善的关系
  • 批准号:
    21K11310
  • 财政年份:
    2021
  • 资助金额:
    $ 2.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了